Stocklytics Platform
Asset logo for symbol CCCC
C4 Therapeutics
CCCC66
$4.30arrow_drop_down2.71%-$0.12
High Growth
Penny Stock
Asset logo for symbol CCCC
CCCC66

$4.30

arrow_drop_down2.71%

Performance History

Chart placeholder
Key Stats
Open$4.89
Prev. Close$4.42
EPS-1.71
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$307.06M
PE Ratio-
LOWHIGH
Day Range4.22
5.85
52 Week Range1.06
11.88
Ratios
EPS-1.71

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About C4 Therapeutics (CCCC)

C4 Therapeutics Inc (CCCC) is a biotechnology company that is focused on developing a new class of drugs called Targeted Protein Degradation (TPD). TPD is a novel approach to drug discovery that aims to selectively remove disease-causing proteins from cells. The company's platform utilizes small molecules known as Degronimid™ to tag specific proteins for degradation by the cell's own protein recycling machinery. This approach has the potential to address a wide range of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.
C4 Therapeutics Inc was founded in 2015 and is headquartered in Watertown, Massachusetts. The company went public in October 2020, raising $172.5 million in its initial public offering (IPO). Since then, its stock price has experienced volatility, reflecting the market's perception of the company's potential and progress. As of the most recent trading session, CCCC stock was trading at $25.60 per share, with a 52-week range between $10.02 and $45.92.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Andrew J. Hirsch M.B.A.
Headquarters
Watertown
Employees
146
Exchange
NASDAQ
add C4 Therapeutics  to watchlist

Keep an eye on C4 Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is C4 Therapeutics 's (CCCC) price per share?

The current price per share for C4 Therapeutics (CCCC) is $4.3. The stock has seen a price change of -$0.12 recently, indicating a -2.71% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for C4 Therapeutics (CCCC)?

For C4 Therapeutics (CCCC), the 52-week high is $11.88, which is 175.96% from the current price. The 52-week low is $1.06, the current price is 306.13% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is C4 Therapeutics (CCCC) a growth stock?

C4 Therapeutics (CCCC) has shown an average price growth of -2.59% over the past three years. It has received a score of 83 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying C4 Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is C4 Therapeutics (CCCC) stock price performance year to date (YTD)?

As of the latest data, C4 Therapeutics (CCCC) has a year-to-date price change of -33.97%. Over the past month, the stock has experienced a price change of -28.96%. Over the last three months, the change has been -24.87%. Over the past six months, the figure is -10.68%.
help

Is C4 Therapeutics (CCCC) a profitable company?

C4 Therapeutics (CCCC) has a net income of -$132.49M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -183.86% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $20.76M, although specific revenue growth data is currently not available. Operating income is noted at -$139.03M. Furthermore, the EBITDA is -$115.13M.
help

What is the market capitalization of C4 Therapeutics (CCCC)?

C4 Therapeutics (CCCC) has a market capitalization of $307.06M. The average daily trading volume is 4.7, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level